Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine and rTMS for Disordered Consciousness
NCT02025439Completed
- Sponsor
- Edward Hines Jr. VA Hospital
- Start
- Feb 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of amantadine in disorders of consciousness (DoC), sponsored by Edward Hines Jr. VA Hospital. Primary endpoint: Intensity of Adverse Event at 60 days. Started Feb 2014; status: completed.
02
Drugs
amantadine
03
Conditions
disorders of consciousness (DoC)
Beyond the preview
Go deeper on NCT02025439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02025439.